Gestational diabetes

Where the papers sit

11 papers from the last 6 months study gestational diabetes directly · updated from PubMed 11 Oct 2026

• Gestational Diabetes Risk Factors

  Risk assessment is moving earlier, from recurrence and pre-pregnancy metabolic exposure to first-trimester biomarkers. Menstrual-cycle characteristics, parity, body mass index and prior gestational diabetes recur as clinical predictors. GLP-1 receptor agonist or tirzepatide use raises questions about pharmacodynamic carry-over into pregnancy. Microbiota-associated metabolites may complement established risk factors, but prospective validation remains open.

  4 papers · 36.4%

• Inflammation and GDM Prediction

  Early prediction is shifting toward combined inflammatory, placental and clinical signals rather than glucose testing alone. Periodontal inflammation and markers including MMP9, Tnf and matrix metallopeptidase 8 link maternal inflammation with gestational diabetes. Hematological indices, composite risk tools and placental texture analysis extend prediction to gestational diabetes and hypertensive disorders. These approaches remain observational or require temporal validation before routine use.

  4 papers · 36.4%

• Gestational Diabetes Screening and Risk

  Risk in older or less fertile women, impaired sleep and inconsistent screening are being considered alongside glucose tolerance testing. Delayed childbearing and low fertility may act independently or jointly with age to increase risk. Sleep duration and quality appear relevant to gestational diabetes subtypes, while hospital audits expose gaps in guideline adherence. The common clinical priority is earlier, more reliable identification of women needing testing.

  3 papers · 27.3%